Relapsing forms of multiple sclerosis (MS)

Indication for Glatiramer

Population group: Suitable for both men and women, only adults (18 - 65 years old)

Glatiramer is indicated for the treatment of relapsing forms of multiple sclerosis (MS).

For this indication, competent medicine agencies globally authorize below treatments:

20 mg once daily

Route of admnistration


Defined daily dose

20 - 20 mg

Dosage regimen

From 20 To 20 mg once every day

Detailed description

The recommended dosage in adults is 20 mg of glatiramer acetate, administered as a subcutaneous injection once daily.

At the present time, it is not known for how long the patient should be treated.

A decision concerning long term treatment should be made on an individual basis by the treating physician.

Dosage considerations

A different site should be chosen for every injection, so this will reduce the chances of any irritation or pain at the site of the injection. Sites for self-injection include the abdomen, arms, hips and thighs.

Active ingredient

Glatiramer is presumed to involve modulation of immune processes. Glatiramer is licensed for reduced frequency of relapses in relapsing-remitting multiple sclerosis.

Read more about Glatiramer

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner